Evoke 01 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sandip P. Patel, MD, discusses the exploration of sacituzumab govitecan in the EVOKE-01 and EVOKE-02 trials in NSCLC and expands on future treatment directions with the agent in this patient population.

San diegoUnited statesSandipp patelUniversity of californiaMoores cancer centerInternational associationLung cancerSacituzumab govitecanEvoke 01Evoke 02